Freeman JS et al. - CGM technology provides a useful tool for quantifying the magnitude and frequency of acute diurnal blood glucose fluctuations and can be effectively leveraged to assess the effects of a pharmacological anti-hyperglycemic therapy on aspects of glycemic control that are not well characterized by A1C measurement alone.